Papers
2
Total Citations
10
H-Index
2
About
Dr. Koichiro Akakura is a leading figure in urological oncology and health outcomes research, with a primary focus on prostate cancer management and urinary stone disease. His most impactful work centers on the cost-effectiveness of treatment strategies, particularly through his leadership in the PRIAS-JAPAN study. His landmark 2022 paper, which has garnered 8 citations, provides a critical comparison of medical costs between active surveillance and more aggressive interventions like robot-assisted prostatectomy and hormone therapy for low-risk prostate cancer. This research is pivotal for healthcare policy, demonstrating that active surveillance is not only clinically sound but also economically advantageous in the Japanese healthcare system. Additionally, Dr. Akakura has made significant contributions to clinical guidelines, serving as a key author on the 2025 third edition of the Japanese Clinical Practice Guideline for the Management of Urinary Stones. This work, developed in collaboration with major urological societies, standardizes care for urolithiasis. His research bridges the gap between clinical efficacy and real-world economic impact, offering essential insights for clinicians and policymakers aiming to optimize patient outcomes while managing healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1
- 2